EAD-Net: A Novel Lesion Segmentation Method in Diabetic Retinopathy Using Neural Networks

Cheng Wan1, Yingsi Chen1, Han Li1

  • 1Nanjing University of Aeronautics and Astronautics, College of Electronic and Information Engineering, 211106, China.

Disease Markers
|September 13, 2021
PubMed

Insights

Diabetic retinopathy (DR) detection is improved with EAD-Net, a novel convolutional neural network. This automated method accurately segments microaneurysms and hemorrhages, aiding clinical diagnosis and monitoring of this common fundus disease.

Area of Science:

  • Ophthalmology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Diabetic retinopathy (DR) is a prevalent fundus disease characterized by microvascular lesions like microaneurysms (MAs) and hemorrhages (HEs).
  • Manual annotation of these lesions is time-consuming and labor-intensive for clinical analysis.
  • Accurate detection and counting of DR lesions are crucial for patient monitoring and diagnosis.

Purpose of the Study:

  • To propose a novel segmentation method for accurately detecting and classifying different types of lesions in diabetic retinopathy.
  • To develop an automated system that reduces the burden of manual annotation in clinical settings.
  • To evaluate the performance of the proposed method against existing techniques and datasets.

Main Methods:

  • A convolutional neural network, termed EAD-Net, was developed, comprising encoder, attention, and decoder modules.
  • Fundus images underwent normalization and augmentation before automated feature extraction and pixel-wise label prediction using EAD-Net.
  • Performance was evaluated using metrics such as sensitivity, specificity, accuracy, and Area Under the Precision-Recall curve (AUPR).

Main Results:

  • EAD-Net achieved high performance metrics: 92.77% sensitivity, 99.98% specificity, and 99.97% accuracy on the e_ophtha_EX dataset.
  • Comparable AUPR scores were obtained on the IDRiD dataset.
  • EAD-Net demonstrated superior performance over the original U-net, particularly in sensitivity and F1-score, with nearly a 10% improvement on a local dataset.

Conclusions:

  • The proposed EAD-Net is an effective and novel method for segmenting four distinct types of lesions in diabetic retinopathy.
  • The automated segmentation achieved by EAD-Net holds significant clinical importance for the monitoring and diagnosis of DR.
  • EAD-Net offers a promising automated solution for lesion detection in DR, outperforming existing methods in key metrics.